CD45RB Glycosylation and Ig Isotype Define Maturation of Functionally Distinct B Cell Subsets in Human Peripheral Blood

Open Access
Authors
  • J. Koers
  • S. Pollastro
  • S. Tol
  • I. Pico-Knijnenburg
  • N.I.L. Derksen
  • P.A. van Schouwenburg
  • M. van der Burg
  • S.M. van Ham ORCID logo
  • T. Rispens
Publication date 2022
Journal Frontiers in Immunology
Article number 891316
Volume | Issue number 13
Number of pages 8
Organisations
  • Faculty of Science (FNWI) - Swammerdam Institute for Life Sciences (SILS)
Abstract
Glycosylation of CD45RB (RB+) has recently been identified to mark antigen-experienced B cells, independent of their CD27 expression. By using a novel combination of markers including CD45RB glycosylation, CD27 and IgM/IgD isotype expression we segregated human peripheral blood B cell subsets and investigated their IGHV repertoire and in vitro functionality. We observed distinct maturation stages for CD27-RB+ cells, defined by differential expression of non-switched Ig isotypes. CD27-RB+ cells, which only express IgM, were more matured in terms of Ig gene mutation levels and function as compared to CD27-RB+ cells that express both IgM and IgD or cells that were CD27-RB-. Moreover, CD27-RB+IgM+ cells already showed remarkable rigidity in IgM isotype commitment, different from CD27-RB+IgMD+ and CD27-RB- cells that still demonstrated great plasticity in B cell fate decision. Thus, glycosylation of CD45RB is indicative for antigen-primed B cells, which are, dependent on the Ig isotype, functionally distinct.
Document type Article
Language English
Published at https://doi.org/10.3389/fimmu.2022.891316
Downloads
CD45RB Glycosylation (Final published version)
Supplementary materials
Permalink to this page
Back